REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN THE PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTIINSTITUTIONAL COHORT IN TAIWAN

被引：0
|
作者：
Kuo, Y. C. [1 ]
Chang, K. C. [2 ]
Chen, H. Y. [3 ]
机构：
[1] Linkou Chang Gung Mem Hosp, Taoyuan, Tao, Taiwan
[2] Chang Gung Mem Hosp, Taoyuan, Taiwan
[3] Linkou Chang Gung Mem Hosp, Dept Pharm, Taoyuan, Tao, Taiwan
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD134
引用
收藏
页码：S475 / S475
页数：1
相关论文
共 50 条
  • [1] Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohort
    Jost-Brinkmann, Fabian
    Demir, Muenevver
    Wree, Alexander
    Luedde, Tom
    Loosen, Sven H.
    Mueller, Tobias
    Tacke, Frank
    Roderburg, Christoph
    Mohr, Raphael
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1313 - 1325
  • [2] Real-world experience of atezolizumab/bevacizumab in hepatocellular carcinoma
    Ha, Yeonjung
    Cheon, Jaekyung
    Hwang, Seong Gyu
    Chon, Hong Jae
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S526 - S527
  • [3] Real-world systemic treatment patterns of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma (HCC)
    Singal, A. G.
    Ozgurdal, K.
    Fan, X.
    Vassilev, Z.
    Chen, C-C.
    Multani, J. K.
    Zhou, Z.
    He, J.
    Pisa, F.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S867 - S867
  • [4] Effectiveness and safety of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: A multicenter, retrospective real-world study in China
    Zhang, Hui
    Shao, Minghua
    Tan, Binbin
    Fu, Yin
    Yuan
    Chen, Hailei
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [5] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Mara Persano
    Margherita Rimini
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    Lorenza Rimassa
    José Presa
    Gianluca Masi
    Changhoon Yoo
    Sara Lonardi
    Francesco Tovoli
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Tiziana Pressiani
    Takumi Kawaguchi
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Fabio Piscaglia
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Massimo Iavarone
    Giovanni Di Costanzo
    Fabio Marra
    Mario Scartozzi
    Emiliano Tamburini
    Giuseppe Cabibbo
    Francesco Giuseppe Foschi
    Marianna Silletta
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5591 - 5602
  • [6] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Persano, Mara
    Rimini, Margherita
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Rimassa, Lorenza
    Presa, Jose
    Masi, Gianluca
    Yoo, Changhoon
    Lonardi, Sara
    Tovoli, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Pressiani, Tiziana
    Kawaguchi, Takumi
    Montes, Margarida
    Vivaldi, Caterina
    Solda, Caterina
    Piscaglia, Fabio
    Hiraoka, Atsushi
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Iavarone, Massimo
    Di Costanzo, Giovanni
    Marra, Fabio
    Scartozzi, Mario
    Tamburini, Emiliano
    Cabibbo, Giuseppe
    Foschi, Francesco Giuseppe
    Silletta, Marianna
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5591 - 5602
  • [7] Letter to the editor: Atezolizumab plus bevacizumab for hepatocellular carcinoma in the real world
    Zhang, Junwei
    Fang, Jinyu
    Xun, Ziyu
    Xu, Yiyao
    Lu, Xin
    Zhao, Haitao
    [J]. HEPATOLOGY, 2022, 76 (04) : E84 - E85
  • [8] Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    Takeda, Soichi
    Namisaki, Tadashi
    Tsuji, Yuki
    Fujimoto, Yuki
    Murata, Koji
    Enomoto, Masahide
    Fujinaga, Yukihisa
    Nishimura, Norihisa
    Kitagawa, Koh
    Takaya, Hiroaki
    Kaji, Kosuke
    Inoue, Takashi
    Kawaratani, Hideto
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    [J]. ANTICANCER RESEARCH, 2022, 42 (11) : 5465 - 5473
  • [9] Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice
    Iwamoto, Hideki
    Shimose, Shigeo
    Noda, Yu
    Shirono, Tomotake
    Niizeki, Takashi
    Nakano, Masahito
    Okamura, Shusuke
    Kamachi, Naoki
    Suzuki, Hiroyuki
    Sakai, Miwa
    Kajiwara, Akira
    Itano, Satoshi
    Tanaka, Masatoshi
    Yamaguchi, Taizo
    Kuromatsu, Ryoko
    Koga, Hironori
    Torimura, Takuji
    [J]. CANCERS, 2021, 13 (11)
  • [10] INITIAL EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE
    Iwamoto, Hideki
    Shimose, Shigeo
    Takashi, Niizeki
    Noda, Yu
    Shirono, Tomotake
    Nakano, Masahito
    Okamura, Shusuke
    Kamachi, Naoki
    Suzuki, Hiroyuki
    Kuromatsu, Ryoko
    Koga, Hironori
    Torimura, Takuji
    [J]. HEPATOLOGY, 2021, 74 : 652A - 652A
12345